Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 306

The DOI matches its Crossref record.

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine

Open access
Schrag, Stephanie J., Verani, Jennifer R.·2013·Vaccine
DOI 10.1016/j.vaccine.2012.11.056
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2012.11.056

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Boyer, 1986, Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis, N Engl J Med, 314, 1665, 10.1056/NEJM198606263142603 · DOI · Paper page
  2. Tuppurainen, 1989, Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients, Obstet Gynecol, 73, 583
  3. Garland, 1991, Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis, Aust N Z J Obstet Gynaecol, 31, 119, 10.1111/j.1479-828X.1991.tb01797.x · DOI
  4. American Academy of Pediatrics, 1992, Guidelines for prevention of group B streptococcal infection by chemoprophylaxis, Pediatrics, 90, 775, 10.1542/peds.90.5.775 · DOI · Paper page
  5. Hankins, 1993, Group B streptococcal infections in pregnancy: ACOG's recommendations, ACOG Newslett, 37, 2
  6. AAP, 1997, Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn, Pediatrics, 99, 489
  7. ACOG, 1996, ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173—June 1996. Committee on Obstetric Practice. American College of Obstetrics and Gynecologists, Int J Gynaecol Obstet, 54, 197
  8. Schrag, 2002, A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates, N Engl J Med, 347, 233, 10.1056/NEJMoa020205 · DOI · Paper page
  9. ACOG, 2002, ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns, Obstet Gynecol, 100, 1405
  10. Verani, 2010, Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010, Morb Mortal Wkly Rep, 59, 1
  11. Castor, 2008, Antibiotic resistance patterns in invasive group B streptococcal isolates, Infect Dis Obstet Gynecol, 2008, 727505, 10.1155/2008/727505 · DOI
  12. Allegaert, 2009, Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy, Am J Obstet Gynecol, 200
  13. Factor, 2000, Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The active bacterial core surveillance team, Obstet Gynecol, 95, 377, 10.1016/S0029-7844(99)00549-9 · doi:10.1016/s0029-7844(99)00549-9
  14. Van Dyke, 2009, Evaluation of universal antenatal screening for group B streptococcus, NEJM 2009, 360, 2626, 10.1056/NEJMoa0806820 · DOI · Paper page
  15. Pulver, 2009, Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis, J Perinatol, 29, 20, 10.1038/jp.2008.115 · doi:10.1038/jp.2008.115
  16. Stoll, 2011, Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues, Pediatrics, 127, 817, 10.1542/peds.2010-2217 · DOI · Paper page
  17. Jordan, 2008, Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis, Pediatr Infect Dis J, 27, 1057, 10.1097/INF.0b013e318180b3b9 · DOI · Paper page
  18. Joseph, 1998, Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin, Arch Pediatr Adolesc Med, 152, 35, 10.1001/archpedi.152.1.35 · DOI
  19. Mercer, 1999, Antibiotic use in pregnancy and drug-resistant infant sepsis, Am J Obstet Gynecol, 181, 816, 10.1016/S0002-9378(99)70307-8 · DOI
  20. Terrone, 1999, Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration, Am J Obstet Gynecol, 180, 1345, 10.1016/S0002-9378(99)70017-7 · DOI
  21. Moore, 2003, Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis, Lancet Infect Dis, 3, 201, 10.1016/S1473-3099(03)00577-2 · DOI
  22. Schrag, 2006, Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use, Pediatrics, 118, 570, 10.1542/peds.2005-3083 · DOI
  23. Stoll, 2002, Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants, N Engl J Med, 347, 240, 10.1056/NEJMoa012657 · DOI · Paper page
  24. Stoll, 2005, Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003, Pediatr Infect Dis J, 24, 635, 10.1097/01.inf.0000168749.82105.64 · DOI · Paper page
  25. Lukacs, 2012, Clinical sepsis in neonates and young infants, United States, 1988–2006, J Pediatr, 160, 960, 10.1016/j.jpeds.2011.12.023 · DOI
  26. Lin, 2001, The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease, Am J Obstet Gynecol, 184, 10
  27. Fairlie T, Zell ER, Schrag SJ. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstetrics and Gynecology. 2013, in press. · DOI
  28. Isaacs, 1999, Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia Australasian Study Group for Neonatal Infections, Pediatr Infect Dis J, 18, 524, 10.1097/00006454-199906000-00009 · DOI
  29. Lopez Sastre, 2005, Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention, Acta Paediatr, 94, 7
  30. Edmond, 2012, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis, Lancet, 379, 547, 10.1016/S0140-6736(11)61651-6 · DOI · Paper page
  31. Schrag, 2012, Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa, Pediatr Infect Dis J, 31, 821, 10.1097/INF.0b013e31825c4b5a · DOI
  32. Phares, 2008, Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005, JAMA, 299, 2056, 10.1001/jama.299.17.2056 · DOI · Paper page
  33. Centers for Disease Control and Prevention, 2011, Influenza vaccination coverage among pregnant women—United States, 2010–11 influenza season, Morb Mortal Wkly Rep, 60, 1078
  34. Goldenberg, 2003, The infectious origins of stillbirth, Am J Obstet Gynecol, 189, 861, 10.1067/S0002-9378(03)00470-8 · DOI · Paper page
  35. Turrentine, 2008, Recurrence of group B streptococci colonization in subsequent pregnancy, Obstet Gynecol, 112, 259, 10.1097/AOG.0b013e31817f5cb9 · DOI
  36. Seale, 2011, What is the best way to use conjugate vaccines?, Curr Opin Infect Dis, 24, 219, 10.1097/QCO.0b013e3283468996 · DOI
  37. Dahesh, 2008, Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics, Antimicrob Agents Chemother, 52, 2915, 10.1128/AAC.00461-08 · DOI
  38. Kimura, 2008, First molecular characterization of group B streptococci with reduced penicillin susceptibility, Antimicrob Agents Chemother, 52, 2890, 10.1128/AAC.00185-08 · DOI · Paper page

Cited by

See all 306

Metadata

Authors
Schrag, S. J., & Verani, J. R.
Venue
Vaccine
Publisher
Elsevier BV
Published
2013-08
Volume
31
Pages
D20-D26
ISSN
0264-410X (ISSN-L)
DOI
10.1016/j.vaccine.2012.11.056
OpenAlex
W2087986262
Cited by
306
References
0
FWCI
13.31
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. https://app.cochat.ai/papers/10.1016/j.vaccine.2012.11.056
The paper
Schrag, S. J., & Verani, J. R. (2013). Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. https://doi.org/10.1016/j.vaccine.2012.11.056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.